Deon Schoombie, CEO of Consumer Healthcare Products Australia talks about pharmacy’s role in self-care education and the latest developments on medicine scheduling
Dr Deon Schoombie, CEO of Consumer Healthcare Products Australia (CHP), says in the last year or so, CHP has “had some really good milestones in the long battle for the recognition of the importance of self-care…. and we believe pharmacists remain a critical partner in developing healthcare literacy.”
In this interview, Dr Schoombie discusses:
- Supply issues during the first year of the pandemic, and plans and predictions on supply
- The promotion of responsible self-care, following the late 2020 launch of the Blueprint for Self-Care, endorsed by Health Minister Greg Hunt as part of the national preventative health care strategy
- CHP’s work to develop pharmacy’s role in providing management of minor, or common ailments in pharmacy, including their support of Professor Charlie Benrimoj’s model for the management of minor ailments in pharmacy.
- Cost-effective healthcare management and importantly, better improved health outcomes.
- Improving the rate of health literacy in Australia. “Health literacy rates in Australia are really not great, something like 40% of the adult population are considered as being health literate,” he says.
- Their work with pharmacy groups on a project under the banner ‘everybody knows pharmacy is a reliable source of information’ – moving people from the internet where its often hard to identify reliable sources of information, and get them to go to pharmacists to seek the best advice.
- Has there been any change to the medicine scheduling policy framework? Despite some “interesting switches to S3”, there’s been slow movements in some areas, he says, adding “we need to work with pharmacy and industry on these areas, such as erectile dysfunction for example, to reassure regulators of the safety and protocols to down-schedule safely”.